Carcinoid syndrome differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Carcinoid syndrome must be differentiated from systemic mastocytosis, medullary thyroid carcinoma, irritable bowel syndrome, and malignant neoplasms of the small intestine. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Systemic mastocytosis | *Systemic mastocytosis | ||
*Medullary thyroid carcinoma | *Medullary thyroid carcinoma | ||
*Irritable bowel syndrome | *Irritable bowel syndrome | ||
*Malignant neoplasms of the small intestine | *Malignant neoplasms of the small intestine |
Revision as of 14:42, 17 September 2015
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome differential diagnosis |
Risk calculators and risk factors for Carcinoid syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Carcinoid syndrome must be differentiated from systemic mastocytosis, medullary thyroid carcinoma, irritable bowel syndrome, and malignant neoplasms of the small intestine.
Differential Diagnosis
- Systemic mastocytosis
- Medullary thyroid carcinoma
- Irritable bowel syndrome
- Malignant neoplasms of the small intestine